abstract |
The present invention relates to a topical ophthalmic pharmaceutical composition comprising Regorafenib, a hydrate, solvate or pharmaceutically acceptable salt thereof or a polymorph thereof, and a process for its preparation and its use in the treatment of ophthalmic conditions. |